期刊文献+

190例自身免疫性肝病临床特征分析 被引量:6

Analyses of the clinical features in 190 cases with autoimmune liver diseases
原文传递
导出
摘要 目的比较分析自身免疫性肝炎、原发性胆汁性肝硬化和重叠综合征的临床特征。方法回顾性分析自身免疫性肝炎、原发性胆汁性肝硬化和重叠综合征患者的临床症状、体征、生化检查、免疫球蛋白、自身抗体、肝脏组织学等检查。结果3组均以女性患者多见,以乏力、黄疸、瘙痒、脾大等为主要临床表现;3组患者白蛋白水平均下降,以原发性胆汁性肝硬化组下降最明显(P〈0.05);3组患者总胆红素、直接胆红素、丙氨酸氨基转移酶、天门冬氨酸氨基转氨酶、碱性磷酸酶和γ-谷酰转移酶均有升高,以重叠综合征升高最明显(P〈0.05)。结论自身免疫性肝病患者的临床特征可能对早期诊断有重要意义;肝功能总胆红素、直接胆红素、丙氨酸氨基转移酶、天门冬氨酸氨基转氨酶、碱性磷酸酶和γ-谷酰转移酶等指标升高明显者需警惕重叠综合征的存在。 Objective To analyze the clinical features among patients with autoimmune hepatitis ( AIH), primary biliary cirrhosis (PBC) and overlap syndrome (AIH-PBC). Method To retrospectively analyze the clinical symptoms, physical signs, biochemistry, immunoglobulin, autoantibody, histopathology in patients with autoimmune liver diseases (including 120 AIH,49 PBC and 21 AIH-PBC cases). Results Women were affected more frequently than men. The most common symptoms were fatigue ,jaundice, pruri- tus and splenomegaly in the three groups. Serum albumin (ALB)levels decreased, especially in the PBC group. While the total bilirubin ( TBIL), direct bilirubin ( DBIL ), alanine aminotransferase ( ALT), aspar- tate aminotransferase (AST), serum alkaline phosphatase (ALP)and gamma-glutamyl transpeptidase (GGT) levels increased in the three groups,especially in the AIH-PBC group. Conclusion The clinical features might have significant importance on the early diagnosis of autoimmune liver diseases; If the TBIL,DBIL, ALT, AST, ALP, GGT levels were significantly higher, the presence of overlap syndrome should be alert.
出处 《临床内科杂志》 CAS 2012年第11期739-741,共3页 Journal of Clinical Internal Medicine
关键词 自身免疫性肝炎 原发性胆汁性肝硬化 重叠综合征 Autoimmune hepatitis Primary biliary cirrhosis Overlap syndrome Clinical feature
  • 相关文献

参考文献14

  • 1Czaja AJ, Cassani F, Cataleta M, et al. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. J Hepatol, 1996,24: 1068-1073.
  • 2Ngu JH, Bechly K, Chapman BA, et al. Population-based epidemiology study of autoimmune hepatitis : A disease of older women. J Gastroen- terol Hepato1,2010,25 : 1681-1686.
  • 3Silveira MG, Brunt EM, Heathcote J, et al. American Association for the Study of Liver Diseases Endpoints Conference : Design and Endpoints for Clinical Trials in Primary Biliary Cirrhosis. J Hepatol, 2010, 52: 349-359.
  • 4Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepa- titis Group Report : review of criteria for diagnosis of autoimmune hepati- tis. J Hepatol, 1999,31:929-938.
  • 5Heatheote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatol- ogy,2000,31:1005-1013.
  • 6Chazouill6res O, Wendum D, Serfaty L, et al. Primary biliary cirrhosis- autoimmune hepatitis overlap syndromes:clinical features and response to therapy. J Hepatol, 1998,28:296-301.
  • 7Strassburg CP, Manns MP. Therapy of autoimmune hepatitis. Best Pract Res Clin Gastroenterol,2011,25 :673-87.
  • 8杨晋辉,尤丽英,唐映梅,郑盛,刘海.208例自身免疫性肝病临床分析[J].临床内科杂志,2012,29(2):101-104. 被引量:17
  • 9Sliveira MG, Talwalkar JA, Angulo P, et al. Overlap of hepatitis and pri- mary biliary cirrhosis : long-term outcomes. Am J Gastroenenterol,2007, 102 : 1244-1250.
  • 10Miyake Y, Iwasaki Y, Terada R, et al. Persistent elevation of serum ala- nine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis. Aliment Phar- macol Ther,2006,24 : 1197-1205.

二级参考文献13

  • 1Malik TA, Saeed S. Autoimmune hepatitis : a review. J Pak Med Assoc, 2010,60:381-387.
  • 2Ngu JH, Bechly K, Chapman BA, et al. Population-based epidemiology study of autoimmune hepatitis : A disease of older women? J Gastroenterol Hepatol,2010,25 : 1681-1686.
  • 3Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999,31:929-938.
  • 4Manns MP, Czaja A J, Gorham JD, et al. Diagnosis and Management of Autoimmune Hepatitis. J Hepatol,2010 ,51:2193-2213.
  • 5Yokokawa J, Kanno Y, Saito H. Risk factors associated with relapse of type 1 autoimmune hepatitis in Japan. J Hepatol,2011,41:641-646.
  • 6Yeoman AD, Westbrook RH, Zen Y. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. J Hepatol,2011,53 :926-934.
  • 7Montano-Loza AJ, Carpenter HA, Czaja AJ. Improving the end point of corticosteroid therapy in type-1 autoimmune hepatitis to reduce the frequency of relapse. Am J Gastroenterol,2007,102 : 1005-1012.
  • 8Miyake Y, Iwasaki Y,Terada R, et al. Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis. Aliment Pharmacol Ther,2006,24 : 1197-1205.
  • 9A1-Chalabi T, Underhill J, Portmann BC, et al. Effects of serum aspartate transaminase levels in patients with autoimmune hepatitis influence disease course and outcome. Clin Gastroenterol Hepatol, 2008, 6: 1389-1395.
  • 10Czaja AJ. Performance Parameters of the Conventional Serological Markers for Autoimmune Hepatitis. Dig Dis Sei ,2011,56:545-554.

共引文献21

同被引文献53

  • 1赵亮,刘亮明.自身免疫性肝炎诊疗新进展[J].中华临床医师杂志(电子版),2012,6(20):26-29. 被引量:5
  • 2高冀蓉,乔玲,李侗曾,刘旭华,王颖,孟忻,侯维,李卓,陈义森.原发性胆汁性肝硬化和自身免疫性肝炎重叠综合征患者的临床特征分析[J].中国综合临床,2006,22(9):797-799. 被引量:7
  • 3蔡少平,刘泽.自身免疫性肝炎-原发性胆汁性肝硬化重叠综合征的临床病理研究[J].实用肝脏病杂志,2007,10(4):234-236. 被引量:3
  • 4Achenza MI, Meda F, Brunetta E, et al. Serum autoantibodies for the diagnosis and management of autoimmune liver diseases [ J ]. Expert Rev Gastmenteml Hepatol,2012,6 (6) :717 -729.
  • 5Manns MP, Czaja A J, Gotham JD, et al. Diagnosis and management of autoimmune hepatitis [ J ]. Hepatology, 2010,51 ( 6 ) : 2193 - 2213.
  • 6Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrho- sis[ J]. Hepatology ,2009,50( 1 ) :291 - 308.
  • 7Shvarts Via, Nogaller AM. Autoimmune hepatitis [ J ]. Klin Med (Mosk) ,2013,91 (9) :57 -61.
  • 8Hirschfield GM, Gershwin ME. The immunobiology and pathophys- iology of primary biliary cirrhosis[ J]. Annu Rev Pathol,2013,8: 303 - 330.
  • 9Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31:929-938.
  • 10Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology, 2000,31 : 1005-1013.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部